Instil Bio, Inc.
TIL
$28.30
-$0.11-0.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.39M | -28.20M | -11.90M | -23.02M | -14.92M |
| Total Depreciation and Amortization | 12.00K | 498.00K | 741.00K | 901.00K | 975.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.64M | 19.89M | 4.67M | 11.32M | 4.35M |
| Change in Net Operating Assets | -5.05M | 3.62M | -4.07M | -9.33M | -1.02M |
| Cash from Operations | -14.79M | -4.20M | -10.56M | -20.13M | -10.61M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 13.00K | 405.00K | 320.00K | 5.00K | 541.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -413.00K | 9.21M | 12.68M | 19.81M | 11.38M |
| Cash from Investing | -400.00K | 9.61M | 13.00M | 19.81M | 11.92M |
| Total Debt Issued | -- | -- | 85.60M | -- | -- |
| Total Debt Repaid | -- | -- | -82.84M | -- | -- |
| Issuance of Common Stock | 71.00K | 404.00K | 206.00K | 159.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.61M | -172.00K | -1.37M | -- | -- |
| Cash from Financing | 6.68M | 232.00K | 1.60M | 159.00K | -- |
| Foreign Exchange rate Adjustments | 21.00K | 43.00K | -65.00K | 42.00K | -8.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.49M | 5.69M | 3.97M | -118.00K | 1.30M |